Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Cardiovasc Intervent Radiol ; 41(5): 811-815, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-29344717

RESUMEN

An asymptomatic 48-year-old man presented with multiple aneurysms in a primary racemose hemangioma of the right bronchial artery. Bronchial arteriography revealed a tortuous artery with four fusiform aneurysms of varying sizes and aneurysmal dilatation with marked thrombus formation in the long segment of the distal portion. Because the tip of catheter could not pass beyond the aneurysmal dilatation, we performed balloon-occluded embolization using a mixture of N-butyl-2-cyanoacrylate (NBCA) and iodized oil. For four other aneurysms, we performed embolization using a coil alone or with NBCA. After 6 months, right bronchial arteriography revealed no enhancement of the aneurysms. Despite the rarity of this procedure, embolization with NBCA is a good option for bronchial artery aneurysm embolization.


Asunto(s)
Aneurisma/terapia , Enfermedades Bronquiales/terapia , Embolización Terapéutica/métodos , Enbucrilato/uso terapéutico , Hemangioma/terapia , Aneurisma/complicaciones , Aneurisma/diagnóstico por imagen , Arterias Bronquiales/diagnóstico por imagen , Enfermedades Bronquiales/complicaciones , Enfermedades Bronquiales/diagnóstico por imagen , Angiografía por Tomografía Computarizada/métodos , Diagnóstico Diferencial , Hemangioma/complicaciones , Hemangioma/diagnóstico por imagen , Humanos , Aceite Yodado/uso terapéutico , Masculino , Persona de Mediana Edad
2.
Respir Investig ; 52(6): 357-64, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25453379

RESUMEN

BACKGROUND: Management of chronic thromboembolic pulmonary hypertension (CTEPH) has recently improved because of advances in pulmonary endarterectomy (PEA), balloon pulmonary angioplasty (BPA), and disease-targeted medications. However, patients with inoperable CTEPH or persistent pulmonary hypertension (PH) after these interventions continue to exhibit impaired exercise capacity and limited quality of life (QOL). METHODS: Eight patients with inoperable or residual CTEPH (mean age, 64±12 years; WHO functional class II/III, 6/2; mean pulmonary artery pressure, 47±13 mmHg) in stable condition and receiving disease-targeted medications participated in a 12-week home-based pulmonary rehabilitation program (muscle strength training, respiratory exercises, and walking) with supervised hospital sessions from March 2012 to January 2014. Efficacy parameters were prospectively evaluated at baseline and at completion of the 12-week program. RESULTS: After completion of the pulmonary rehabilitation program, the 6-minute walking distance (6MWD) (33.3±25.1 m), St. George׳s Respiratory Questionnaire activity score, quadriceps force, and 7-day physical activity level were significantly improved compared with baseline. All subjects completed the rehabilitation program. Although one patient experienced presyncope during the in-hospital exercise sessions, no other severe adverse events or complications of pulmonary rehabilitation were observed. CONCLUSIONS: These findings suggest that home-based pulmonary rehabilitation with closely supervised sessions may safely improve exercise capacity, leg muscle strength, general activity in daily life and health-related QOL in CTEPH patients.


Asunto(s)
Servicios de Atención de Salud a Domicilio , Hipertensión Pulmonar/fisiopatología , Hipertensión Pulmonar/rehabilitación , Pulmón/fisiopatología , Embolia Pulmonar/rehabilitación , Actividades Cotidianas , Anciano , Ejercicios Respiratorios , Enfermedad Crónica , Ejercicio Físico , Femenino , Humanos , Pierna/fisiopatología , Persona de Mediana Edad , Actividad Motora , Fuerza Muscular , Evaluación de Programas y Proyectos de Salud , Embolia Pulmonar/fisiopatología , Calidad de Vida , Resultado del Tratamiento , Caminata
3.
Intern Med ; 52(13): 1499-502, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23812198

RESUMEN

Although the link between pulmonary arterial hypertension (PAH) and exposure to certain drugs has already been identified, we herein present the first case of herbal medicine-associated PAH in which the patient demonstrated spontaneous remission. A 38-year-old woman took the herbal medicine "bofutsushosan" for two weeks then stopped taking it due to exertional dyspnea. However, her dyspnea continued, and right heart catheterization revealed a mean pulmonary arterial pressure of 41 mmHg with a normal wedge pressure. Several months after treatment with oxygen therapy, the patient's dyspnea disappeared, and her pulmonary arterial pressure normalized. Further studies focusing on susceptibility factors to drug-induced pulmonary arterial hypertension are needed.


Asunto(s)
Medicamentos Herbarios Chinos/efectos adversos , Hipertensión Pulmonar/inducido químicamente , Hipertensión Pulmonar/diagnóstico , Remisión Espontánea , Adulto , Hipertensión Pulmonar Primaria Familiar , Femenino , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA